Edgar Filing: Ondis April

Ownership Submission

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Â Ondis April

2. Date of Event Requiring Statement (Month/Day/Year)
07/20/2011

3. Issuer Name and Ticker or Trading Symbol
ASTRO MED INC /NEW/ [ALOT]

(Last)

(First)

(Middle)

C/O ASTRO-MED, INC.,Â 600 EAST GREENWICH AVENUE

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	__X__ 10% Owner
_____ Officer (give title below)	_____ Other (specify below)

5. If Amendment, Date Original Filed(Month/Day/Year)

(Street)

PROVIDENCE,Â RIÂ 02893

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	1,557,357	D ⁽¹⁾	Â

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (right to purchase)	03/18/2002	03/18/2012	Common Stock	2,062.5	$ 2.6909	D	Â
Stock Option (right to purchase)	03/24/2003	03/24/2013	Common Stock	2,062.5	$ 2.4	D	Â
Stock Option (right to purchase)	04/19/2004	04/19/2014	Common Stock	3,437.5	$ 8.7273	D	Â
Stock Option (right to purchase)	03/21/2005	03/21/2015	Common Stock	1,562.5	$ 6.768	D	Â
Stock Option (right to purchase)	03/20/2006	03/20/2016	Common Stock	937.5	$ 7.9316	D	Â
Stock Option (right to purchase)	03/26/2007	03/26/2017	Common Stock	1,200	$ 11.895	D	Â
Stock Option (right to purchase)	04/01/2008	04/01/2018	Common Stock	600	$ 8.95	D	Â
Stock Option (right to purchase)	03/18/2009	03/18/2019	Common Stock	600	$ 6.22	D	Â
Stock Option (right to purchase)	03/15/2010	03/15/2020	Common Stock	1,000	$ 7.36	D	Â
Stock Option (right to purchase)	03/14/2011	03/14/2021	Common Stock	1,000	$ 7.95	D	Â
Stock Option (right to purchase)	03/18/2002	03/18/2012	Common Stock	85,250	$ 2.6909	I	See footnote ⁽²⁾
Stock Option (right to purchase)	04/19/2004	04/19/2014	Common Stock	41,250	$ 8.7273	I	See footnote ⁽²⁾
Stock Option (right to purchase)	03/20/2006	03/20/2016	Common Stock	21,250	$ 7.9316	I	See footnote ⁽²⁾
Stock Option (right to purchase)	04/12/2007	04/12/2017	Common Stock	14,000	$ 11.445	I	See footnote ⁽²⁾
Stock Option (right to purchase)	04/01/2008	04/01/2018	Common Stock	6,275	$ 9.845	I	See footnote ⁽²⁾
Stock Option (right to purchase)	03/18/2009	03/18/2019	Common Stock	5,000	$ 6.842	I	See footnote ⁽²⁾
Stock Option (right to purchase)	03/15/2010	03/15/2021	Common Stock	5,000	$ 8.096	I	See footnote ⁽²⁾

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Ondis April C/O ASTRO-MED, INC. 600 EAST GREENWICH AVENUE PROVIDENCE,Â RIÂ 02893	Â	Â X	Â	Â

Signatures

Margaret D. Farrell (Attorney-in-fact for April Ondis)		08/01/2011
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Includes (i) 1,608,631 shares which are held by the Estate of Albert W. Ondis of which the reporting person is a co-executor, (ii) 1,658 shares held in trust for a child of the reporting person of which the reporting person is a trustee and (iii) 487 shares which are held under the issuer's employee stock ownership plan for the account of the reporting person.
(2)	Stock Options are held by the Estate of Albert W. Ondis of which the reporting person is a co-executor.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.